In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination method

被引:15
|
作者
Li, Bing-Ke [1 ]
Cong, Yong [1 ]
Yang, Xue-Gang [1 ]
Xue, Ying [1 ,2 ]
Chen, Yi-Zong [3 ]
机构
[1] Sichuan Univ, Coll Chem, Minist Educ, Key Lab Green Chem & Technol, Chengdu 610064, Peoples R China
[2] Xihua Univ, Key Lab Adv Sci Computat Sichuan Prov, Chengdu 610039, Peoples R China
[3] Natl Univ Singapore, Dept Pharm, Bioinformat & Drug Design Grp, Singapore 117543, Singapore
基金
中国国家自然科学基金;
关键词
Machine learning methods (ML methods); Recursive feature elimination (RFE); Support vector machine (SVM); Spleen tyrosine kinase (Syk); Rheumatoid arthritis (RA); RHEUMATOID-ARTHRITIS; CHEMICAL-COMPOUNDS; POTENT INHIBITORS; SYK; CLASSIFICATION; DISCOVERY; SELECTION; TARGETS; DESIGN; DERIVATIVES;
D O I
10.1016/j.compbiomed.2013.01.015
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We tested four machine learning methods, support vector machine (SVM), k-nearest neighbor, back-propagation neural network and C4.5 decision tree for their capability in predicting spleen tyrosine kinase (Syk) inhibitors by using 2592 compounds which are more diverse than those in other studies. The recursive feature elimination method was used for improving prediction performance and selecting molecular descriptors responsible for distinguishing Syk inhibitors and non-inhibitors. Among four machine learning models, SVM produces the best performance at 99.18% for inhibitors and 98.82% for non-inhibitors, respectively, indicating that the SVM is potentially useful for facilitating the discovery of Syk inhibitors. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:395 / 404
页数:10
相关论文
共 7 条
  • [1] Computational Prediction of Influenza Neuraminidase Inhibitors Using Machine Learning Algorithms and Recursive Feature Elimination Method
    Zhang, Li
    Ai, Haixin
    Zhao, Qi
    Zhu, Junfeng
    Chen, Wen
    Wu, Xuewei
    Huang, Liangchao
    Yin, Zimo
    Zhao, Jian
    Liu, Hongsheng
    BIOINFORMATICS RESEARCH AND APPLICATIONS (ISBRA 2017), 2017, 10330 : 344 - 349
  • [2] A Machine Learning Approach to EEG-based Prediction of Human Affective States Using Recursive Feature Elimination Method
    Dadebayev, Didar
    Wei, Goh Wei
    Xion, Tan Ee
    14TH INTERNATIONAL ENGINEERING AND COMPUTING RESEARCH CONFERENCE SHAPING THE FUTURE THROUGH MULTIDISCIPLINARY RESEARCH (EURECA 2020), 2021, 335
  • [3] Establishing a prediction model of severe acute mountain sickness using machine learning of support vector machine recursive feature elimination
    Min Yang
    Yang Wu
    Xing-biao Yang
    Tao Liu
    Ya Zhang
    Yue Zhuo
    Yong Luo
    Nan Zhang
    Scientific Reports, 13 (1)
  • [4] Establishing a prediction model of severe acute mountain sickness using machine learning of support vector machine recursive feature elimination
    Yang, Min
    Wu, Yang
    Yang, Xing-biao
    Liu, Tao
    Zhang, Ya
    Zhuo, Yue
    Luo, Yong
    Zhang, Nan
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [5] In silico prediction of multiple-category classification model for cytochrome P450 inhibitors and non-inhibitors using machine-learning method
    Lee, J. H.
    Basith, S.
    Cui, M.
    Kim, B.
    Choi, S.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2017, 28 (10) : 863 - 874
  • [6] Interpretable Machine Learning Models for Molecular Design of Tyrosine Kinase Inhibitors Using Variational Autoencoders and Perturbation-Based Approach of Chemical Space Exploration
    Krishnan, Keerthi
    Kassab, Ryan
    Agajanian, Steve
    Verkhivker, Gennady
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [7] In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches
    Ajmal, Amar
    Danial, Muhammad
    Zulfat, Maryam
    Numan, Muhammad
    Zakir, Sidra
    Hayat, Chandni
    Alabbosh, Khulood Fahad
    Zaki, Magdi E. A.
    Ali, Arif
    Wei, Dongqing
    PHARMACEUTICALS, 2024, 17 (05)